Clara Bodelon, Ph.D., M.S., joined DCEG as a postdoctoral fellow in January 2011. She received her Ph.D. in mathematics from Boston University in 2001. From 2002 to 2006, Dr. Bodelon did postdoctoral research at The Salk Institute (La Jolla, CA) attempting to understand the dynamics of visual processing. In 2009, Dr. Bodelon received a Master of Science degree in epidemiology from the University of Washington. While working on this degree, she examined the association between the use of analgesics and the risk of endometrial cancer. She also studied relationships between hormonally-related factors and esophageal cancer and the immunogenetic susceptibility of cervical and vulvar cancers. In 2015, she transitioned to the Clinical Genetics Branch (CGB), where she is working with Nicolas Wentzensen, M.D., Ph.D., Deputy Chief and senior investigator, CGB, on projects related to the molecular epidemiology of ovarian cancer.
Ronald Eldridge, Ph.D., M.P.H., joined the Hormone and Reproductive Epidemiology Branch (HREB) in September of 2014 as a NCI Cancer Prevention Fellow, and transitioned to the Clinical Genetics Branch (CGB) in 2015. Prior to joining NCI, he obtained his B.S. in biology from Loyola University Chicago, and his M.P.H. and Ph.D. in epidemiology from Emory University. During his graduate studies, he conducted research in the fields of breast, colorectal, and pancreatic cancers by investigating the genetic, behavioral, and demographic causes of those cancers. His doctoral dissertation examined the harmful effects oxidative stress has on colorectal adenoma, and how obesity increases adenoma risk through the oxidative stress process. In CGB, Dr. Eldridge is continuing to pursue his research interests of mediation analysis and molecular mechanisms, primarily in gynecological cancers. He is currently working under the mentorship of Nicolas Wentzensen, M.D., Ph.D., Deputy Chief and senior investigator, CGB, to clarify the molecular and epidemiologic reasons that increase a woman's risk of cervical and endometrial cancers.
Payal Khincha, M.B.B.S., has joined the Clinical Genetics Branch (CGB) as a clinical fellow. Dr. Khincha first came to CGB as a special volunteer and clinical collaborator in July 2012 for the research component of a clinical fellowship in pediatric hematology-oncology at the Children’s National Medical Center (CNMC), Washington, D.C., which she recently completed. She received her M.B.B.S. degree in 2005 from Kempegowda Institute of Medical Sciences, Bangalore, India, and completed her residency training in pediatrics in 2010 at Maimonides Medical Center, Brooklyn, New York and CNMC, Washington D.C. Dr. Khincha began her clinical pediatric hematology-oncology fellowship at CNMC in 2011, and as part of her research component at CGB, focused on the clinical management, diagnosis, and genotype-phenotype relationships of dyskeratosis congenita (DC), a cancer-prone inherited bone marrow failure syndrome and telomere biology disorder. As a clinical fellow in CGB, Dr. Khincha works with Sharon A. Savage, M.D., Chief of CGB, on DC and telomere biology studies, and with Dr. Savage and Phuong Mai, M.D., on the Li-Fraumeni Syndrome study.
Kate Rendle, Ph.D., M.S.W., M.P.H., joined the Clinical Genetics Branch (CGB) as a Cancer Prevention Fellow in August 2015. Dr. Rendle earned her Ph.D. in social work and anthropology from the University of Michigan in 2014. Her doctoral research investigated how provider communication, public debates, and cultural anxieties about the HPV vaccine impact parental vaccination decisions in the United States. In May 2015, Dr. Rendle earned an M.P.H. in epidemiology from the University of California, Berkeley. Dr. Rendle has a broad range of research interests centered on using epidemiological approaches to examine healthcare delivery and outcomes. Her current interests include understanding multi-level factors associated with cancer prevention behaviors (including HPV vaccination, genetic testing, and cancer screening) and implementing evidence-based, patient-centered care across different healthcare contexts. In CGB, Dr. Rendle is working with Mark Greene, M.D., senior investigator, and Mark Schiffman, M.D., M.P.H, senior investigator, and also with Sarah Kobrin, Ph.D., M.P.H., in the Health Systems and Interventions Research Branch.
Michelle Silver, Ph.D., Sc.M., joined the Clinical Genetics Branch (CGB) as an NCI Cancer Prevention Fellow in November 2015. Dr. Silver received her B.A. in human biology from Stanford University. She earned both her Sc.M. and her Ph.D. in epidemiology from the Johns Hopkins University Bloomberg School of Public Health, where she received an R36 Dissertation Research Grant from the Agency for Health Care and Research Quality to support her research. Her dissertation focused on the changing cervical cancer screening guidelines and their translation into clinical practice in the United States. In CGB, under the mentorship of Mark Schiffman, M.D., M.P.H., senior investigator, Dr. Silver is exploring applied/translational epidemiology and how to best use the results of epidemiologic studies to make evidence-based decisions in cancer screening and prevention, both domestically and internationally.
Jenni Young, M.A., M.S., LGMFT, joined the Clinical Genetics Branch (CGB) of NCI as a predoctoral fellow in September, 2014. She is a first year family science doctoral student at the University of Maryland, College Park. She earned a B.A. in psychology and Mandarin Chinese from the University of Wisconsin, Madison, and an M.A. in Chinese language and culture from The Ohio State University. Ms. Young graduated from the University of Maryland’s Couple and Family Therapy M.S. Program in May and is a licensed Couple and Family Therapist in the state of Maryland. In CGB, she works with Mark H. Greene, M.D., senior investigator, and Jennifer T. Loud, R.N., C.R.N.P., D.N.P., Assistant Branch Chief, doing psychosocial and qualitative research on Li-Fraumeni syndrome families.